IVAInventiva S.A. American Depository Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key: 17310
Ticker: IVA
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-07-10
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: IVA

Detail

Enriched 2026-08-14 20:47

Market cap: $1,105,578,995.04
Shares outstanding (class): 209,007,475
Shares outstanding (weighted): 236,234,828
SIC: —
Employees: 77
Location: —
Homepage: https://www.inventivapharma.com
Description: Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Market cap and share counts drift.

Funds holding this security

3 funds · 3 positions · $2.40M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
Simplify Propel Opportunities ETF Simplify Exchange Traded Funds	SURI	$1.26M	1.82%	227,923 NS	FIGI
Artisan International Small-Mid Fund Artisan Partners Funds Inc.	—	$1.09M	0.04%	195,745 NS	FIGI
U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS	—	$51.2K	0.02%	9,220 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERIVA
FIGI_COMPOSITEBBG00VM4C335
FIGI_SHARE_CLASSBBG00VM4C3W3
CIK0001756594
ISINUS46124U1079
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Inventiva is a biopharmaceutical company developing therapies, fitting the biotechnology industry within healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.